|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4178 | |
| A61K 31/445 | |||
| A61K 31/473 | |||
| A61K 31/27 | |||
| A61K 31/55 | |||
| A61K 31/4748 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2478099 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10817543.1 |
| Europos patento paraiškos padavimo data | 2010-09-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/002475 |
| Data | 2010-09-13 |
| (87) | Numeris | WO 2011/034568 |
| Data | 2011-03-24 |
| (30) | Numeris | Data | Šalis |
| 272382 P | 2009-09-18 | US |
| (72) |
CHASE, Thomas N., US
CLARENCE-SMITH, Kathleen E., US
|
| (73) |
Chase Pharmaceuticals Corporation,
5 Giralda Farms,, Madison, New Jersey 07940,
US
|
| (54) | COMBINATION FOR TREATING ALZHEIMER-TYPE DEMENTIA |
| COMBINATION FOR TREATING ALZHEIMER-TYPE DEMENTIA |